Patents by Inventor Michael Kaufman

Michael Kaufman has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20190318068
    Abstract: A computer-implemented method of improving data access in an organization by a computer. The computer receives a command from an individual to perform an action on a data element to the organization. Responsive to receiving the command, the computer reads an authorization object assigned to the data element. Responsive to reading the authorization object, the computer creates list of individuals authorized to perform the action on the data element in accordance with the authorization object. Responsive to creating the list, the computer permits the action on the data element only if the individual is on the list.
    Type: Application
    Filed: April 17, 2018
    Publication date: October 17, 2019
    Inventors: Jason F. Melo, Michael Hirawady, Kuntal Roy, Meng-Yi Hsu, Lucky Ratanlal Jain, Dennis Peter Mohan, Shia Kaufman
  • Patent number: 10423174
    Abstract: A pulse frequency modulated (PFM) voltage converter autonomously switches between buck, buck-boost, and boost modes as a function of the input and output voltages. The voltage converter may also switch autonomously between buck mode and a low drop out (LDO) mode when configured in a system in which the battery voltage is known to always be higher than the output voltage.
    Type: Grant
    Filed: April 23, 2018
    Date of Patent: September 24, 2019
    Assignee: Silicon Laboratories Inc.
    Inventors: Jeffrey L. Sonntag, Dazhi Wei, Michael D. Mulligan, Zachary A. Kaufman, Joselyn Torres-Torres
  • Publication number: 20190254274
    Abstract: A bio-active composite material includes one or more organic molecules, each organic molecule including a metal coordinating functional group and an inorganic core attached to the organic molecule. The inorganic core includes one or more metals. The metals may be noble metals and/or non-noble metals. The non-noble metals may be alkali, alkaline earth, transition, post-transition, and metalloid materials. The organic molecule and inorganic core are attached by a covalent bond or a non-covalent bond.
    Type: Application
    Filed: February 20, 2019
    Publication date: August 22, 2019
    Applicant: ADA Foundation
    Inventors: Stanislav Frukhtbeyn, Thomas C. Hart, Michael S. Valerio, Jeffrey J. Kim, Gili Kaufman
  • Patent number: 10294623
    Abstract: A self-aligning and torque transmitting coupler assembly includes an outer coupler coupled to a first shaft of and an inner coupler coupled to a second shaft. The outer coupler comprises an inner surface having primary and secondary alignment and torque transmitting features, and the inner coupler comprises an outer surface having primary and secondary alignment features. The primary and secondary alignment features are configured to interlock and facilitate alignment of the first and second shafts along a common axis in an exemplary application of a foundation support system.
    Type: Grant
    Filed: December 6, 2017
    Date of Patent: May 21, 2019
    Assignee: PIER TECH SYSTEMS, LLC
    Inventors: Kevin Kaufman, Michael D. Wilkis
  • Publication number: 20190091146
    Abstract: A controlled release dosage form containing monomethyl fumarate, a compound that can be metabolized into monomethyl fumarate in vivo, or a pharmaceutically acceptable salt thereof or combinations thereof wherein the monomethyl fumarate, a compound that can be metabolized into monomethyl fumarate in vivo, or a pharmaceutically acceptable salt thereof or combinations thereof is delivered to the subject. Also provided is a method of treating a disease or disorder (e.g., multiple sclerosis) by orally administering a controlled release dosage form containing monomethyl fumarate, a compound that can be metabolized into monomethyl fumarate in vivo, or a pharmaceutically acceptable salt thereof or combinations thereof, wherein the monomethyl fumarate, a compound that can be metabolized into monomethyl fumarate in vivo, or a pharmaceutically acceptable salt thereof or combinations thereof.
    Type: Application
    Filed: November 26, 2018
    Publication date: March 28, 2019
    Applicant: Biogen MA Inc.
    Inventors: Peter Zawaneh, Shyam B. Karki, Michael Kaufman, Cheuk-Yui Leung, Jinquan Dong, Ernest Quan, Kalyan Vasudevan
  • Publication number: 20190008768
    Abstract: A controlled release dosage form containing monomethyl fumarate, a compound that can be metabolized into monomethyl fumarate in vivo, or a pharmaceutically acceptable salt thereof or combinations thereof, wherein the monomethyl fumarate, a compound that can be metabolized into monomethyl fumarate in vivo, or a pharmaceutically acceptable salt thereof or combinations thereof is delivered to the subject. Also provided is a method of treating a disease or disorder (e.g., multiple sclerosis) by orally administering a controlled release dosage form containing monomethyl fumarate, a compound that can be metabolized into monomethyl fumarate in vivo, or a pharmaceutically acceptable salt thereof or combinations thereof, wherein the monomethyl fumarate, a compound that can be metabolized into monomethyl fumarate in vivo, or a pharmaceutically acceptable salt thereof or combinations thereof.
    Type: Application
    Filed: September 14, 2018
    Publication date: January 10, 2019
    Applicant: Biogen MA Inc.
    Inventors: Peter Zawaneh, Shyam B. Karki, Michael Kaufman, Cheuk-Yui Leung, Jinquan Dong, Ernest Quan, Kalyan Vasudevan
  • Patent number: 10172794
    Abstract: A controlled release dosage form containing monomethyl fumarate, a compound that can be metabolized into monomethyl fumarate in vivo, or a pharmaceutically acceptable salt thereof or combinations thereof, wherein the monomethyl fumarate, a compound that can be metabolized into monomethyl fumarate in vivo, or a pharmaceutically acceptable salt thereof or combinations thereof is delivered to the subject. Also provided is a method of treating a disease or disorder (e.g., multiple sclerosis) by orally administering a controlled release dosage form containing monomethyl fumarate, a compound that can be metabolized into monomethyl fumarate in vivo, or a pharmaceutically acceptable salt thereof or combinations thereof, wherein the monomethyl fumarate, a compound that can be metabolized into monomethyl fumarate in vivo, or a pharmaceutically acceptable salt thereof or combinations thereof.
    Type: Grant
    Filed: December 12, 2014
    Date of Patent: January 8, 2019
    Assignee: Biogen MA Inc.
    Inventors: Peter Zawaneh, Shyam B. Karki, Michael Kaufman, Cheuk-Yui Leung, Jinquan Dong, Ernest Quan, Kalyan Vasudevan
  • Patent number: 9684561
    Abstract: A smart assistant scans or directs the scanning of a network and clients connected to the network to ensure that the clients will be properly backed up. When the smart assistant detects a change in the network, a client, or both, the smart assistant seeks the approval of a backup administrator to automatically update backup configuration information based on the detected change. If the backup administrator approves the approval request, the smart assistant automatically updates the backup configuration information. If the backup administrator denies the approval request, the smart assistant does not update the backup configuration information.
    Type: Grant
    Filed: September 29, 2014
    Date of Patent: June 20, 2017
    Assignee: EMC IP Holding Company LLC
    Inventors: Meng Yan, Vijuna Benedict, Rajesh Ramsoondar, Michael Kaufman
  • Publication number: 20160310419
    Abstract: A controlled release dosage form containing monomethyl fumarate, a compound that can be metabolized into monomethyl fumarate in vivo, or a pharmaceutically acceptable salt thereof or combinations thereof, wherein the monomethyl fumarate, a compound that can be metabolized into monomethyl fumarate in vivo, or a pharmaceutically acceptable salt thereof or combinations thereof is delivered to the subject. Also provided is a method of treating a disease or disorder (e.g., multiple sclerosis) by orally administering a controlled release dosage form containing monomethyl fumarate, a compound that can be metabolized into monomethyl fumarate in vivo, or a pharmaceutically acceptable salt thereof or combinations thereof, wherein the monomethyl fumarate, a compound that can be metabolized into monomethyl fumarate in vivo, or a pharmaceutically acceptable salt thereof or combinations thereof.
    Type: Application
    Filed: December 12, 2014
    Publication date: October 27, 2016
    Inventors: Peter Zawaneh, Shyam B. Karki, Michael Kaufman, Cheuk-Yui Leung, Jinquan Dong, Ernest Quan, Kalyan Vasudevan
  • Publication number: 20130282080
    Abstract: A phototherapy treatment dispensing device provides therapeutic light emissions treatments. The device provides additional means for controlling a patient's exposure to those treatments through a controlled protocol timer. The controlled protocol timer can provide for incremental exposure increases; monitors patient compliance with a treatment regimen; and reminds the patient when a treatment will soon be overdue.
    Type: Application
    Filed: June 18, 2013
    Publication date: October 24, 2013
    Inventors: Steven Hendrix, Kenneth Oif, Michael Kaufman
  • Publication number: 20130245724
    Abstract: A phototherapeutic device comprises a system for facilitating phototherapeutic treatment. The system comprises an input device configured to receive input from a user. The system further comprises a display device configured to communicate information to the user. The system further comprises a controller. The controller is configured to receive user identification data from the input device. The controller is further configured to retrieve treatment history based on the user identification data. The controller is further configured to retrieve a treatment protocol based on the user identification data. The controller is further configured to generate a suggested treatment based on the retrieved treatment history and the retrieved treatment protocol. The controller is further configured to communicate the suggested treatment to the display device.
    Type: Application
    Filed: March 13, 2013
    Publication date: September 19, 2013
    Applicant: National Biological Corporation
    Inventor: Michael Kaufman
  • Patent number: 8486124
    Abstract: A phototherapy treatment dispensing device provides therapeutic light emissions treatments. The device provides additional means for controlling a patient's exposure to those treatments through a controlled protocol timer. The controlled protocol timer can provide for incremental exposure increases; monitors patient compliance with a treatment regimen; and reminds the patient when a treatment will soon be overdue.
    Type: Grant
    Filed: November 15, 2007
    Date of Patent: July 16, 2013
    Assignee: National Biological Corporation
    Inventors: Steven Hendrix, Kenneth Oif, Michael Kaufman
  • Publication number: 20130138648
    Abstract: A system and method for validation, review, approval, editing, developing, publishing, and/or ongoing maintenance of a digital document, the system and method having the functionality to work alone or can be used in conjunction with other software applications and workflows in order to facilitate the direct review of documents.
    Type: Application
    Filed: January 28, 2013
    Publication date: May 30, 2013
    Inventor: Jason Michael Kaufman
  • Publication number: 20120292427
    Abstract: Various embodiments of the present disclosure provide a combination strapping package and dispenser that includes a first strapping coil holding compartment and a second strapping coil holding compartment configured to be nested together and to define a coil receiving or holding area. The combination strapping package and dispenser is configured to hold a strapping coil during shipment from the manufacturer or distributor to the end user and additionally during the use of the strapping by the end user such that the end user does not need to remove the strapping coil from the combination strapping package and dispenser. In certain embodiments, the combination strapping package and dispenser of the present disclosure is configured for mid-range amounts of coil which are easier to transport and use, is compostable, and requires less cost to ship.
    Type: Application
    Filed: April 5, 2012
    Publication date: November 22, 2012
    Applicant: IIIinois Tool Works Inc.
    Inventors: Michael Kaufman, Rolando Antonio, Jeffrey Hochleutner, Dennis Miller
  • Publication number: 20120156648
    Abstract: An apparatus for delivering at least one therapeutic agent to a dental tissue of a subject includes at least one electrode, a medicament layer including at least one therapeutic agent, an electrical signal source, and logic configured to control the electrical signal source. At least one electrode has oppositely disposed, dental mouthpiece-shaped first and second major surfaces. The first major surface is curved such that the first major surface substantially conforms to the contour of the dental tissue when placed in contact with the dental tissue. The medicament layer is disposed on at least a portion of the second major surface. The electrical signal source provides a signal having certain characteristics and is electrically connected to at least one electrode. The certain characteristics comprise at least one orienting frequency and at least one motivating frequency sufficient to motivate at least one therapeutic agent into the dental tissue.
    Type: Application
    Filed: December 9, 2011
    Publication date: June 21, 2012
    Applicant: BUCKEYE DENTAL, LLC
    Inventors: MICHAEL KAUFMAN, ALAN T. RIGA
  • Publication number: 20080125834
    Abstract: A phototherapy treatment dispensing device provides therapeutic light emissions treatments. The device provides additional means for controlling a patient's exposure to those treatments through a controlled protocol timer. The controlled protocol timer can provide for incremental exposure increases; monitors patient compliance with a treatment regimen; and reminds the patient when a treatment will soon be overdue.
    Type: Application
    Filed: November 15, 2007
    Publication date: May 29, 2008
    Applicant: NATIONAL BIOLOGICAL CORPORATION
    Inventors: Steven Hendrix, Kenneth Oif, Michael Kaufman
  • Publication number: 20080114006
    Abstract: The present invention relates to novel kinase inhibitors and modulator compounds useful for the treatment of various diseases. More particularly, the invention is concerned with such compounds, kinase/compound adducts, methods of treating diseases, and methods of synthesis of the compounds. Preferrably, the compounds are useful for the modulation of kinase activity of Raf kinases and disease polymorphs thereof. Compounds of the present invention find utility in the treatment of mammalian cancers and especially human cancers including but not limited to malignant melanoma, colorectal cancer, ovarian cancer, papillary thyroid carcinoma, non small cell lung cancer, and mesothelioma. Compounds of the present invention also find utility in the treatment of rheumatoid arthritis and retinopathies including diabetic retinal neuropathy and macular degeneration.
    Type: Application
    Filed: September 12, 2007
    Publication date: May 15, 2008
    Applicant: Deciphera Parmaceuticals, LLC
    Inventors: Daniel Flynn, Peter Petillo, Michael Kaufman, William Patt
  • Publication number: 20080090856
    Abstract: The present invention is concerned with novel compounds useful in the treatment of hyperproliferative diseases and mammalian cancers, especially human cancers. The invention also pertains to methods of modulating kinase activities, pharmaceutical compositions, and methods of treating individuals, incorporating or using the compounds. The preferred compounds are active small molecules set forth in formulae Ia-Iww.
    Type: Application
    Filed: October 10, 2007
    Publication date: April 17, 2008
    Applicant: Deciphera Pharmaceuticals, LLC
    Inventors: Daniel Flynn, Peter Petillo, Michael Kaufman
  • Publication number: 20080046462
    Abstract: A software system automatically and dynamically generates a fully functional user interface (UI) based upon, and connected directly to, an underlying data model (as instantiated within a relational database management system (RDBMS)). The UI derives from an automated interrogation of the RDBMS, and comprises all mode displays (e.g., browse, search, edit, add) for all tables, and a full complement of mechanisms—integrated directly into the mode displays—for representing, navigating, and managing relationships across tables, regardless of the complexity of the underlying RDBMS schema. It utilizes a hierarchical “context stack” for suspending the working state of a particular table while “drilling down” to work with related-table information and return relevant changes to the base table.
    Type: Application
    Filed: October 26, 2007
    Publication date: February 21, 2008
    Inventors: Michael Kaufman, Micah Silverman
  • Patent number: 7213686
    Abstract: A scissor lift mechanism (1) having at least two scissor elements (4, 5) connected in pairs by a swivel axis (3). The drive (11) for raising and lowering the scissor elements (4, 5) is provided by a traction member (13). To reduce the driving power required for operation while at the same time reducing control complexity, the scissor lift mechanism (1) is equipped with two coupling bridges (14, 15) situated on opposite sides of the swivel axis (3) and pivotably supported by thrust struts (22, 23) on each of the two scissor elements (4, 5), respectively. The distance “a” between the coupling bridges (14, 15) and the resulting height of lift “h” are easily variable by applying a tractive force “F” via the traction member (13, 25) which is guided around reversing rollers (16) and back and forth along a plurality of generally parallel paths (18, 19, 20, 21) between the two coupling bridges (14, 15).
    Type: Grant
    Filed: March 4, 2004
    Date of Patent: May 8, 2007
    Assignee: Pro Hub Hebetechnik GmbH
    Inventor: Michael Kaufman